- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Cannabix Technologies Updates on Marijuana Breathalyzer Development
Cannabix Technologies (CSE:BLO) and University of Florida chemists have confirmed that the company’s unique FAIMS cell, coupled with mass spectrometry, has the ability to detect THC.
Cannabix Technologies (CSE:BLO) and University of Florida chemists have confirmed that the company’s unique FAIMS cell, coupled with mass spectrometry, has the ability to detect THC.
As quoted in the press release:
We have successfully isolated THC and THC-related by-products in controlled simulated breath samples, with the current FAIMS-MS configuration demonstrating THC detection limits which are at least 10 times more sensitive than previously reported in the exhaled breath literature. The Company also reports that it has been evaluating the feasibility of detecting other volatile compounds of interest using FAIMS-MS with promising preliminary results for cocaine models in simulated breath samples.
Development of the Cannabix instrument is rapidly advancing. Many proprietary components, such as a high-voltage generator, non-radioactive ionization source, and array detector are being integrated with the novel FAIMS cell to provide the most technologically advanced FAIMS-based instrument in the world.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.